Friday, December 13, 2013
Add My Products
CHU20 Maxi-Cooled: High speed, high resolution electrophoresis with the maxi-cooled horizontal
CHU25 Maxi-Plus Cooled: High speed, high throughput electrophoresis with the maxi-plus cooled horizontal
HU10 Mini-Plus - The 10cm wide mini-plus horizontal
HU13 Midi - The 13cm wide midi horizontal
HU15 Standard - Setting the standard for horizontal gel electrophoresis
HU20 Maxi-Standard - The 20cm wide maxi-standard horizontal
HU25 Maxi-Plus Standard: High throughput separations with the maxi-plus standard horizontal
HU6 Mini - The 6cm wide mini horizontal
SVG-SYS Vari-gel MINI System: Two gel trays for one gel tank with the 7cm Vari-gel mini system
The Easigel H1-Set: The fast mini horizontal
Showing Results 1 - 10 of 29
Bridgepoint Development Capital to Acquire Quotient Clinical
Quotient Clinical has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum.
UConn Chemist Discovers New Way to Stabilize Proteins
Discovery could lead to the development of stable vaccines and affordable artificial blood substitutes.
'Smuggling' Drugs at the Cellular Level
Drexel researchers use ultrasound to deliver customized medication through the skin.
Nanosponge Vaccine Fights MRSA Toxins
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA could serve as a safe and effective vaccine against this toxin.
Drug Testing without the Pain at Queen’s
Microneedles on a sticking-plaster-like patch may be the painless and safe way doctors will test for drugs and some infections in the future.
UK Scientists to Begin Trial of Potential HIV Cure
Scientists and clinicians from five leading UK universities will begin a groundbreaking clinical trial next year to test a possible cure for HIV infection.
Key HIV Protein Structure Revealed
Researchers have developed a more detailed picture of the protein largely responsible for enabling HIV to enter human immune cells and cause infection.
New European Vaccine Initiative
Leading organisations have joined forces to rapidly assess and communicate the benefits and risks of vaccines.
Major Breakthrough in the Fight against Antibiotic Resistance
'Resistance breaker’ compounds have been described as the most important innovation in the discovery of new antibiotics since Alexander Fleming’s original breakthrough.
NIH Launches Trial of Investigational Genital Herpes Vaccine
Trial will test an investigational HSV-2 vaccine candidate, called HSV529.
Advertise On This Site
Terms & Conditions
©2013 Technology Networks
, all rights reserved.